Healthcare professionals’ perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Healthcare professionals’ perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda ; volume:19 ; number:1 ; day:10 ; month:2 ; year:2020 ; pages:1-12 ; date:12.2020
Malaria journal ; 19, Heft 1 (10.2.2020), 1-12, 12.2020
- Urheber
-
Ndagije, Helen Byomire
Kiguba, Ronald
Manirakiza, Leonard
Kirabira, Elijah
Sserwanga, Allan
Nabirye, Leah
Mukonzo, Jackson
Olsson, Sten
Spinewine, Anne
D’Hoore, William
Speybroeck, Niko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12936-020-3148-5
- URN
-
urn:nbn:de:101:1-2020051015102835197771
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ndagije, Helen Byomire
- Kiguba, Ronald
- Manirakiza, Leonard
- Kirabira, Elijah
- Sserwanga, Allan
- Nabirye, Leah
- Mukonzo, Jackson
- Olsson, Sten
- Spinewine, Anne
- D’Hoore, William
- Speybroeck, Niko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Initial surveillance of suspected undesirable drug reactions to some Artemisinin-based combination therapies (ACTs) in Lagos, Nigeria
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018–2019
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Novel artemisinin-based antiviral, antimalarial and anticancer hybrid compounds via click chemistry
Initial surveillance of suspected undesirable drug reactions to some Artemisinin-based combination therapies (ACTs) in Lagos, Nigeria
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018–2019
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Novel artemisinin-based antiviral, antimalarial and anticancer hybrid compounds via click chemistry
Initial surveillance of suspected undesirable drug reactions to some Artemisinin-based combination therapies (ACTs) in Lagos, Nigeria
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018–2019
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts